Benzyl acrylate (stabilised with MEHQ), 99.00%, 500g

2-BROMO-5-CHLOROPYRIDINE-3-BORONIC ACID, 97.0%, 1g

6-chloro-N~2~,N~2~-dimethyl-2,4-pyrimidinediamine, 95.0%, 1g

4-(Trifluoromethoxy)isophthalonitrile, 97.0%, 10g

N-(3-Butynyl)phthalimide, 97.0%, 10g

(2E)-3-[4-(benzyloxy)phenyl]-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

N-(3-Pyridyl)pivalamide>98.0%(GC)(T)5g

Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

4-(3-(Trifluoromethyl)phenoxy)phenylthiourea, 97%, 10g

ethyl 2-(3-chloropropanamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate, 95.0%, 500mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 100–500, 16 mm, 1 Piece(s)

TERT-BUTYL 3-METHOXY-4-NITROBENZOATE, 95.0%, 250mg

2-(Methylthio)pyrimidin-4(3H)-one, 98.0%, 10g